Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice.
Purified pyocin, administered parenterally to mice infected with sensitive strains of Pseudomonas aeruginosa, afforded significant protection against two of the three strains studied.
D000818:Animals; D001430:Bacteriocins / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008815:Mice, Inbred Strains; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa
D001430:Bacteriocins